Earnings Call/Transcript
Meghmani Organics Q2 FY27 Earnings Call
Meghmani Organics will hold a post-results earnings call on 5 November 2026 at 11:00 AM IST to discuss Q2 FY27 financial results.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
5
Neutral
4
Bullish
5
Bearish
37
Neutral
4
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
1,333 Cr
High Risk
20.8
18.4
0.1
0.9
82.48
36.41
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 03, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Meghmani Organics Ltd (MOL) is currently trading at 52.43 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Meghmani Organics Limited is an integrated Indian chemicals company manufacturing and selling agrochemicals and specialty pigments, operating multiple manufacturing facilities including three major pigment plants and extensive agrochemical capacity, with product lines spanning pesticide intermediates, technicals, formulations and specialty nano-fertilizers. Q1 FY27 results showed standalone revenue near INR523 crores, down about 12% year-on-year, while net profit rose 42% to nearly INR58 crores and EBITDA improved 16% to approximately INR94 crores, reflecting management’s focus on product mix, pricing discipline, and operational efficiencies despite softer demand and lower utilization. The firm derives roughly 75% of revenue from Crop Protection and 25% from Pigments; pigment capacity utilization was low at about 39% in the quarter, while the company has suspended titanium dioxide (TiO2) operations due to extreme sulfur feedstock cost inflation and weakened price realization following anti-dumping changes. Strategic actions include commissioning a Nano Urea plant at Sanand, expanding the nano-fertilizer basket, commissioning a co-generation power plant at the TiO2 site, and integrating Kilburn Chemicals’ multi-product plant at Dahej, signaling sustained capex-backed growth initiatives and consolidation to improve efficiencies and margins.
Over the past 52 weeks, Meghmani Organics Ltd has traded between a low of ₹36.41 and a high of ₹82.48. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Meghmani Organics Ltd has a market capitalization of approximately 1,395.17. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Meghmani Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.72 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,395.17 Cr, Meghmani Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Meghmani Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Meghmani Organics Ltd is 21.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Consolidated net profit was ₹48.19 crore in Q1FY27 versus ₹12.68 crore in Q1FY26, while revenue from operations fell 11.54% YoY to ₹542.83 crore.
Meghmani Organics is proposing to amalgamate Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited with Meghmani Organics Limited as the transferee company.
It is a plan to merge its wholly-owned subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited into Meghmani Organics Limited, with an appointed date of January 1, 2026.
The stock saw sustained selling pressure through the week ending 6 March 2026, alongside concerns highlighted in the note around losses, falling sales and rising interest costs.
Earnings Call/Transcript
Meghmani Organics will hold a post-results earnings call on 5 November 2026 at 11:00 AM IST to discuss Q2 FY27 financial results.
Credit Rating
Meghmani Organics received India Ratings’ IND A/Stable/IND A1 ratings for bank loan facilities totaling INR 11,000 million.
Board Meeting
Meghmani Organics will meet on November 4, 2026, to consider unaudited standalone and consolidated results for Q2 and the half year ended September 30, 2026.
